VanEck Pharmaceutical ETF Rating $106.47 0.00 (0.00%) As of 06/12/2026 03:59 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock VanEck Pharmaceutical ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PPH Aggregate RatingModerate Buy 2.62Holdings in PPH have an aggregate rating of Moderate Buy based on 338 analyst ratings issued in the past year covering 22 companies (85.6% of the portfolio).PPH Aggregate Price Target$106.47High Prediction$106.47Average Prediction$106.47Low Prediction$106.47Holdings in PPH have an aggregate price target of $106.47 and a range of $106.47 to $106.47 covering 22 companies (85.6% of the portfolio).PPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by VanEck Pharmaceutical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 PPH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings22.69%LLYEli Lilly and Company$1,137.01+0.4%4.1028 of 5 stars2.87$1,227.74 8.0%30Trending NewsAnalyst Revision9.59%MRKMerck & Co., Inc.$119.05+0.0%4.468 of 5 stars2.68$128.18 7.7%19Trending NewsOptions VolumeGap Up5.55%NVONovo Nordisk A/S$43.90+0.0%4.2431 of 5 stars2.13$65.56 49.3%23Trending NewsAnalyst Revision4.78%PFEPfizer$26.19-0.1%3.842 of 5 stars2.25$28.82 10.1%20Trending NewsAnalyst Downgrade4.36%SNYSanofi$44.254.0366 of 5 stars2.47$51.00 15.3%154.31%BMYBristol Myers Squibb$57.05-0.1%4.7181 of 5 stars2.37$61.31 7.5%19Trending News4.25%ABBVAbbVie$227.54-0.1%4.4846 of 5 stars2.88$253.43 11.4%25Trending News4.22%GSKGSK$53.04+0.0%2.8334 of 5 stars2.00$53.00 -0.1%10Dividend Cut4.08%JNJJohnson & Johnson$240.57-0.1%4.417 of 5 stars2.74$253.04 5.2%27Trending NewsInsider Trade3.75%MCKMcKesson$783.880.0%4.9071 of 5 stars2.82$960.53 22.5%17Positive NewsShort Interest Increase3.23%CORCencora$281.560.0%4.8604 of 5 stars2.80$374.00 32.8%15Positive News3.17%TEVATeva Pharmaceutical Industries$34.58-0.2%4.549 of 5 stars2.80$41.78 20.8%10Positive News2.89%HLNHaleon$9.13+0.0%3.1819 of 5 stars2.7582.62%TAKTakeda Pharmaceutical$15.92+0.0%3.1561 of 5 stars2.5042.30%ZTSZoetis$79.51-0.1%4.9653 of 5 stars2.33$133.92 68.4%15Trending NewsGap Up1.04%VTRSViatris$16.483.2458 of 5 stars2.43$17.50 6.2%7News CoveragePositive News1.00%JAZZJazz Pharmaceuticals$230.563.3405 of 5 stars2.84$246.06 6.7%19Trending NewsInsider Trade0.70%AXSMAxsome Therapeutics$255.171.6771 of 5 stars2.95$256.79 0.6%210.39%CORTCorcept Therapeutics$82.913.8275 of 5 stars2.75$88.83 7.1%8Positive News0.34%ELANElanco Animal Health$24.19+0.1%3.5723 of 5 stars2.77$28.20 16.6%13Positive News0.22%OGNOrganon & Co.$13.46+0.1%2.932 of 5 stars1.71$11.40 -15.3%7Positive News0.07%PRGOPerrigo$10.98-0.1%3.7595 of 5 stars2.00$19.33 76.1%6 This page (NASDAQ:PPH) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VanEck Pharmaceutical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share VanEck Pharmaceutical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PPH Stock Alerts